To: John J H Kim who wrote (5387 ) 2/10/1998 9:39:00 PM From: Tunica Albuginea Read Replies (1) | Respond to of 23519
JohnJHKim," VVUS is performing poorly today when a very good part of the market is surging ahead ". Vivus been doing that for the past year. Typically goes down when market is up. That is how you unnerve hapless investors and get them to sell at a loss;then the Institution buys it back and sells it higher. Difficult to tell were Vivus will be any day of the future.It all depends how panicky shareholders get holding it, GG. Personally I think at this point it is very difficult to time things. Everybody seems to be bubbling on again while the White House scandal is rumbling along with Asia. This market has one foot in the grave and one on a banana peel IMHO.In the past when market tanked Vivus actually did pretty good. With the forth coming good news, whether you buy at 14, 13, 12 or 10 doesn't really matter that much. When Vivus starts selling like M&Ms it will be fire crackers.Remember that 75% of the gains in stocks occurs in less than 5% of threading days if my memory is correct. My hardest decision now is to decide when to sell after Vivus hits 20. If by that time the market is down, you could buy some good stuff I hope with some of the Vivus gains. On the other hand there's not too many other stocks that will give you the burning growth of Vivus. The last few days volume is down.Today Leland's sales notice in other times would have caused a much larger fall in stock price than it did. Also the yesterday's? sale by those large holders. I think that many money managers are as ignorant about the technologies of the stocks they are buying as can be, from selling MSFT at $20 on down. What is so remarkable to me is that 1 year ago, without any large studies at all ;based on a group of just 12 patients with ED described as " of no known organic cause " meaning they could have been completely normal;in the Brit Jour of Urolgy; 2 allegedly top Urologists ( Padma and Goldstein); both with poor knowledge of pharmacology in general being Urologists), embraced Viagra; along with assorted investors in PFE: guided by the Wall Street Journal/Barrons, which hasn't turned a profit to it's shareholders for the past 6 years;both wholeheartedly embraced Viagra on the basis of no data;one(Padma) repudiated? what he had just written about MUSE in the NEJM; the other Goldstein condemned MUSE? Alprostadil while at the same time doing the same time doing research on the very same drug Alprostadil for Harvard Scientific.All these people decided on the basis of scant to no data that Viagra would be a cure all for all ED; an illness so complex of which we know so little off. Amazing. Only in America? TA